Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radiologische Allianz is a Germany-based physician-led radiology, nuclear medicine, and radiation therapy group centered in Hamburg and surrounding areas. The organization operates a large outpatient and clinic-linked network offering diagnostic imaging such as MRI, CT, X-ray, neuroradiology, mammography, PET/CT, nuclear medicine, radiation therapy, and radiosurgery including Gamma Knife services. It appears to function primarily as a care delivery network rather than a drug-development biotech or pharmaceutical company. The group emphasizes advanced equipment, digital image access, interdisciplinary collaboration, and partnerships with hospitals and referring physicians. For a biotech analyst, this is best categorized as a commercial healthcare services and diagnostics provider, not a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radiologische Allianz.